September 2009 Medtech Financings

With medtech investments in July and August each at over $400 million, I had hopes (expectations?) that September would continue the trend, but through Sept. 30, medtech financings for the month totaled "only" $328 million. Of course, this is still a healthy amount, especially considering that September investment tends to be lower on a relative basis anyway. 

 

September 2009 Medtech Financings: 

  • Endosense, Inc., has raised $36 million in a Series B financing (catheter ablation of cardiac arrhythmias)
  • Athena Feminine Technologies has raised $2 million in a Series A financing (pelvic floor electrical stimulation for treatment of urinary incontinence) 
  • ValenTx, Inc., has raised $22 million in Series B financing (minimally invasive treatment of obesity)
  • LifeWave Hi-Tech Medical Devices Ltd has raised $1.5 million in a secondary offering (electrical stimulation device for chronic wound treatment)
  • Uptake Medical, Inc., has raised $3.4 million of a planned $13.4 million financing according to a regulatory filing (broncoscopic catheters for treatment of emphysema and chronic obstructive pulmonary disease)
  • Nuveta, Inc., has raised $800K in a Series A financing (in vitro fertilization technologies)
  • Virtual Ports, Ltd., has raised $2.6 million in early stage financing (developing surgical endoscopy technology)
  • Pervasis Therapeutics, Inc., has raised $17 million in a Series C financing (Vascugel, a product derived from tissue-engineered allogeneic endothelium for enhancing blood vessel repair)
  • Calypso Medical Technologies, Inc., has raised $50 million in venture capital financing (tumor localization technology for use during external beam radiation therapy)
  • Update Medical, Inc., has raised $3.4 million of a planned $13.3 million financing (bronchoscopic lung volume reduction treatment for COPD)
  • NewCardio, Inc., has raised $2.9 million in a private placement (platform technology for improvement in 12-lead EKG)
  • Spinal Kinetics, Inc., has raised $5.3 million in a financing round (artifical discs for treatment of spinal injuries and degenerative disc disease)
  • Gamma Medica-Ideas, Inc., has raised $24 million in its institutional investor financing round (digital molecular imaging system for detection of cancer)
  • Micell Technologies, Inc., has received a $15 million investment from St. Jude Medical (drug-coated stents designed to be less thrombogenic)
  • Monteris Medical, Inc., has raised $2 million of a planned $3.5 million round of financing (tumor ablation applicable to brain)
  • Ionix Medical, Inc. (formerly OncoStim), has raised $18.3 million in financing according to a regulatory filing (minimally invasive device for treatment of BPH and prostate cancer)
  • Sleep Solutions, Inc., has raised $20 million according to a regulatory filing (sound analysis technology for in-home monitoring of sleep-disordered breathing)
  • MedShape Solutions, Inc., announced that it had closed $10 million in equity funding (memory shape device technologies in orthopedics)
  • Zogenix, Inc., closes $51 million Series B funding (needlefree subcutaneous drug delivery system)
  • Urodynamix Technologies Ltd raises $1.5 million in private placement (near infrared spectroscopy in diagnosis and treatment of urinary incontinence)
  • Spartek Medical, Inc., has raised $3.2 million in financing according to a regulatory filing (minimally invasive treatment of degenerative disc disease)
  • ActiViews Ltd has raised $5 million in a financing round (optical guidance in CT, fluoroscopy and MRI for oncology diagnosis)
  • ThermalTherapeutic Systems, Inc., has raised $2.75 million in a new round of funding (portable device to heat and circulate sterile fluids)
  • Blue Belt Technologies, Inc., has raised $2.4 million in a Series A round of funding (surgical instruments in orthopedics and neurosurgery)
  • Inspired Surgical Technologies, Inc., has raised $1 million in financing according to a regulatory filing (photonic based surgical technologies platform)
  • Satiety, Inc., has raised $25.3 million of a planned $33 million round of financing (obesity device) 

Posted via email from medmarket’s posterous

Leave a Reply